CDC reported how coronavirus disease 2019 (COVID-19) mortality rates varied among unvaccinated and vaccinated adults aged ≥65 years.
CHMP recommends against Mirati’s KRAS rival, in favor of Pfizer’s RSV vaccine, other drugs
The European Medicines Agency’s human medicines committee (CHMP) recommended against conditional authorization for Mirati’s KRAS G12C inhibitor Krazati in non-small cell lung cancer this week,